You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The researchers believe that their prototype could be the basis of a portable, point-of-care testing platform that would enable rapid testing anywhere.
In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.
The Guardian writes that researchers are examining whether small genetic changes account for the different COVID-19 disease courses people experience.
A UK study has found that antibodies against SARS-CoV-2 may decline over time, Reuters reports.
The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.
The new method incorporates analysis of the amplification and melt curves and was used to create a single-channel nonaplex test using intercalating dye.
Using transcription data from cells and nuclei, the researchers uncovered heterogeneity within cardiac cells and mapped them to particular regions of the heart.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
The test is based on 13 genes that form a gene signature in the blood of children with Kawasaki disease, and it enables KD to be distinguished from other diseases.
New Scientist reports that researchers have found a quadruple-stranded form of DNA within healthy human cells.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.